PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: November 2012
Hepatitis C: Engaging Patients Online
Given the amount of activity in the hepatitis C drug development space – as evidenced in PharmExec’s 2013 Pipeline report – patients are scouring the internet for information on the disease, available treatments, and soon to be available treatments. A new Industry Standard Research report examines the digital cracks consumers encounter when looking for [...]
Posted in Advertising, E-Media, Marketing, Strategy, multimedia, patient education, social media Tagged Genentech, Hepatitis C, online marketing, online strategy, Roche, Search, social media, Vertex Leave a comment
Pharma in the Dell: Working with Academia
How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.
Posted in Biotech, Deals, IP, Meetings, People, R&D, Strategy, Technology, leadership Tagged Celera, Data, Gilead, Intellectual property, Janssen, Mount Sinai School of Medicine, Pfizer Leave a comment
Dissecting ACA's Section 6004: Tipping the Balance on Sampling Controls?
With the Affordable Care Act [ACA] officially settling into the US’ political landscape, a pressing – but little noticed – issue is the provisions for increased compliance on industry promotion practices. Of specific concern is Section 6004 of the ACA, which demands more rigorous reporting on the distribution of free samples to physicians from pharmaceutical [...]
Posted in FDA, Manufacturing, Regulatory, compliance 1 Comment
Pipeline Report Preview
Posted in Advertising, Biotech, Europe, FDA, Gene therapy, Global, IP, R&D, Regulatory, Strategy, Video Tagged business, Eli Lilly, Europe, FDA, Merck, Pfizer, pipeline, R&D, Strategy, United States Leave a comment
Pharma Forecast 2020: Cold Comfort